WebMD Extends Poison Pill Defense

Don't let it get away!

Keep track of the stocks that matter to you.

Help yourself with the Fool's FREE and easy new watchlist service today.

NEW YORK (AP) --€” WebMD (Nasdaq: WBMD  ) extended its poison pill defense, first put into place to ward off billionaire investor Carl Icahn, for another two years.

The company is struggling to maintain advertising revenue as drugmakers pull back spending at the online health information company.

It also changed the plan, so that it will not count stock grants to the company's directors when determining whether a shareholder becomes an "acquiring person" under the plan.

Poison pill measures are designed to prevent unwanted attempts to acquire or take control of a company by giving other shareholders the right to purchase more company stock at a discount, thereby diluting the shares held by the potential suitor and making it more costly to take over the company.

WebMD slashed the purchase price for shareholders if the rights are exercised to $66.29 from $153. Shareholders will have a chance to vote on the changes at the company's upcoming 2013 shareholder meeting.

The company originally adopted the plan in November 2011 after Icahn revealed he had a nearly 8 percent stake in the company. Icahn later increased his stake to about 13 percent.

WebMD's sites include WebMD Health, MedicineNet, RxList, and It has been under pressure recently as drug companies cut back on advertising and it faces more competition from social networking sites and ad networks.

The company's stock has tumbled more than 60 percent this year and it said in July that it expects to post a loss for this year.

Shares of WebMD Health fell 10 cents to $14.10 in midday trading.

The Motley Fool has no positions in the stocks mentioned above. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2066315, ~/Articles/ArticleHandler.aspx, 10/22/2016 8:00:45 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 10 hours ago Sponsored by:
DOW 18,145.71 -16.64 -0.09%
S&P 500 2,141.16 -0.18 -0.01%
NASD 5,257.40 15.57 0.30%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/21/2016 4:00 PM
WBMD $51.59 Up +0.97 +1.92%
WebMD Health CAPS Rating: **